Inappropriate ICD therapy: Does device configuration make a difference

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 8, 2006, Pages 810-815

  Soundarraj, Dwarakraj ^a   Thakur, Ranjan K ^a   Gardiner, Joseph C ^a   Khasnis, Atul ^a   Jongnarangsin, Krit ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Complications; Implantable defibrillator; Inappropriate shocks; Sinus tachycardia; Supraventricular arrhythmias

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; DIGOXIN; DIURETIC AGENT; NITRATE; SOTALOL;

ADULT; AGE; AGED; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DRUG USE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; REVIEW; RISK FACTOR; SEX; SINUS TACHYCARDIA; STATISTICAL ANALYSIS; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL TIME;

AGED; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; ELECTRIC COUNTERSHOCK; EQUIPMENT FAILURE; FEMALE; HEART ARREST; HUMANS; INCIDENCE; MALE; MICHIGAN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 33747137546     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00445.x     Document Type: Review

References (31)

1. Nunain SO, Roelke M, Trouton T, Osswald S, Kim YH, Sosa-Suarez G, Brooks DR, et al. Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation 1995; 91:2204-2213.
2. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation 1993; 87:1880-1888.
3. Fogoros RN, Elson JJ, Bonnet CA. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1989; 12:1465-1473.
4. Rosenqvist M, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: A prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998; 98:663-670.
5. Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, Gilkerson J, et al. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J 2000; 139:797-803.
6. Goldberger JJ, Horvath G, Challapalli R, Kadish AH. Inappropriate implantable cardioverter-defibrillator therapy due to the detection of premature ventricular complexes. Pacing Clin Electrophysiol 1999; 22:825-828.
7. Healy E, Ngarmukos T, Rosenthal L. Case of bad timing: Inappropriate implantable cardioverter defibrillator therapy due to a critically placed premature ventricular contraction. Pacing Clin Electrophysiol 2002; 25:1403-1405.
8. Mela T, Ngarmukos T, Rosenthal L, Mittleman R. Inappropriate ICD therapy due to lead-related noise in an active fixation ICD lead. J Invasive Cardiol 2001; 13:406-408.
9. Sandler MJ, Kutalek SP. Inappropriate discharge by an implantable cardioverter defibrillator: Recognition of myopotential sensing using telemetered intracardiac electrograms. Pacing Clin Electrophysiol 1994; 17:665-671.
10. Washizuka T, Chinushi M, Kasai H, Watanabe H, Tagawa M, Hosaka Y, Abe A, et al. Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing. Jpn Circ J 2001; 65:685-687.
11. Shivkumar K, Feliciano Z, Boyle NG, Wiener I. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection. J Cardiovasc Electrophysiol 2000; 11:1285-1288.
12. Weretka S, Becker R, Hilbel T, Karle C, Osswald BR, Kuebler W, Schoels W. Far-field R wave oversensing in a dual chamber arrhythmia management device: Predisposing factors and practical implications. Pacing Clin Electrophysiol 2001; 24:1240-1246.
13. Takahashi T, Bhandari AK, Watanuki M, Cannom DS, Sakurada H, Hiraoka M. High incidence of device-related and lead-related complications in the dual-chamber implantable cardioverter defibrillator compared with the single-chamber version. Circ J 2002; 66:746-750.
14. Schreieck J, Zrenner B, Kolb C, Ndrepepa G, Schmitt C. Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2001; 24:1154-1157.
15. Dijkman B, Wellens HJ. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000; 11:1105-1115.
16. Sticherling C, Schaumann A, Klingenheben T, Hohnloser SH. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. Europace 1999; 1:96-102.
17. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, et al. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol 2001; 12:134-142.
18. Trappe HJ, Achtelik M, Pfitzner P, Voigt B, Weismuller P. Single-chamber versus dual-chamber implantable cardioverter defibrillators: Indications and clinical results. Am J Cardiol 1999; 83:8D-16D.
19. Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, et al. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol 2002; 13:1183-1199.
20. Pinski SL, Fahy GJ. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 1995; 92:1651-1664.
21. Wolpert C, Jung W, Scholl C, Spehl S, Cyran J, Luderitz B. Electrical proarrhythmia: Induction of inappropriate atrial therapies due to far-field R wave oversensing in a new dual chamber defibrillator. J Cardiovasc Electrophysiol 1998; 9:859-863.
22. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, et al. Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-3123.
23. Dijkman B, Wellens HJ. Importance of the atrial channel for ventricular arrhythmia therapy in the dual chamber implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 2000; 11:1309-1319.
24. Proclemer A, Della Bella P, Facchin D, Fattore L, Carbucicchio C, Tondo C, Lunati M, et al. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: A retrospective analysis in the single-chamber defibrillator era. Europace 2001; 3:132-135.
25. Nanthakumar K, Dorian P, Paquette M, Greene M, Edwards J, Heng D, Noble J, et al. Is inappropriate implantable defibrillator shock therapy predictable? J Interv Card Electrophysiol 2003; 8:215-220.
26. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993; 87:VI102-VI110.
27. Seidl K, Senges J. Worldwide utilization of implantable cardioverter/defibrillators now and in the future. Card Electrophysiol Rev 2003; 7:5-13.
28. Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients. J Cardiovasc Electrophysiol 2002; 13:38-43.
29. Geelen P, Lorga Filho A, Chauvin M, Wellens F, Brugada P. The value of DDD pacing in patients with an implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1997; 20:177-181.
30. Higgins SL, Williams SK, Pak JP, Meyer DB. Indications for implantation of a dual-chamber pacemaker combined with an implantable cardioverter- defibrillator. Am J Cardiol 1998; 81:1360-1362.
31. Nielsen JC, Mortensen PT, Pedersen AK. Long-term follow-up of patients treated with implantable cardioverter defibrillators in a Danish centre. Accurrence ICD therapy and patient survivors. Scand Cardiovasc J 1997; 31:151-156.